Excitatory Amino Acid Receptors in the Ventral Tegmental Area Regulate Dopamine Release in the Ventral Striatum

Authors

  • Mignon Karreman,

    1. Department of Psychiatry, Yale University School of Medicine and V.A. Medical Center, West Haven, Connecticut, U.S.A.; and
    2. University Centre for Pharmacy, Department of Medicinal Chemistry, University of Groningen, Groningen, The Netherlands
    Search for more papers by this author
  • Ben H. C. Westerink,

    1. University Centre for Pharmacy, Department of Medicinal Chemistry, University of Groningen, Groningen, The Netherlands
    Search for more papers by this author
  • Bita Moghaddam

    Corresponding author
    1. Department of Psychiatry, Yale University School of Medicine and V.A. Medical Center, West Haven, Connecticut, U.S.A.; and
    Search for more papers by this author

Address correspondence and reprint requests to Dr. B. Moghaddam at Department of Psychiatry, Yale University School of Medicine, V.A. Medical Center 116A/2, West Haven, CT 06516, U.S.A.

Abstract

Abstract: The role of excitatory amino acid (EAA) receptors located in the ventral tegmental area (VTA) in tonic and phasic regulation of dopamine release in the ventral striatum was investigated. Microdialysis in conscious rats was used to assess dopamine release primarily from the nucleus accumbens shell region of the ventral striatum while applying EAA antagonists or agonists to the VTA. Infusion of the AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (25 and 100 µM) into the VTA did not affect dopamine release in the ventral striatum. In contrast, intra-VTA infusion of the NMDA receptor antagonist 2-amino-5-phosphopentanoic acid (100 and 500 µM) dose-dependently decreased the striatal release of dopamine. Intra-VTA application of the ionotropic EAA receptor agonists NMDA and AMPA dose-dependently (10 and 100 µM) increased dopamine efflux in the ventral striatum. However, infusion of 50 or 500 µM trans-(±)-1-amino-1,3-cyclopentanedicarboxylic acid (ACPD), a metabotropic EAA receptor agonist, did not significantly affect these levels. These data suggest that NMDA receptors in the VTA exert a tonic excitatory influence on dopamine release in the ventral striatum. Furthermore, dopamine neurotransmission in this region may be enhanced by activation of NMDA and AMPA receptors, but not ACPD-sensitive metabotropic receptors, located in the VTA. These data further suggest that EAA regulation of dopamine release primarily occurs in the VTA as opposed to presynaptically at the terminal level.

Ancillary